Lynne Abruzzo: Difference between revisions
Appearance
Content deleted Content added
#1lib1ref |
|||
Line 46: | Line 46: | ||
*https://pathology.osu.edu/ext/faculty/abruzzo.html |
*https://pathology.osu.edu/ext/faculty/abruzzo.html |
||
* {{cite web | title=Deletion 20q in CLL May Represent Disease Progression | website=OncLive | date=2015-05-28 | url=https://www.onclive.com/web-exclusives/deletion-20q-in-cll-may-represent-disease-progression | ref={{sfnref | OncLive | 2015}} | access-date=2018-05-16}} |
|||
{{Authority control}} |
{{Authority control}} |
||
Revision as of 18:34, 16 May 2018
Lynne V Abruzzo | |
---|---|
Education | Baylor College of Medicine, National Institute of Diabetes, Digestive, and Kidney Diseases, National Cancer Institute, University of Chicago |
Medical career | |
Profession | Medicine |
Field | Pathology |
Institutions | The Ohio State University |
Sub-specialties | Cytogenetics |
Lynne V. Abruzzo is an American science researcher, currently at Ohio State University and an Elected Fellow of the American Association for the Advancement of Science.[1][2]
Life
She graduated from Baylor College of Medicine, National Cancer Institute, NIH, and National Institute of Diabetes Digestive, and Kidney Diseases, NIH.[3]
References
- ^ "Abruzzo, Lynne". aaas.org. Retrieved April 21, 2017.
- ^ "Lynne V. Abruzzo". osu.edu. Retrieved April 21, 2017.
- ^ "Dr. Lynne V Abruzzo - Cancer Researcher at OSUCCC - James". The James - OSUCCC. Retrieved 2018-05-16.
External links
- "Deletion 20q in CLL May Represent Disease Progression". OncLive. 2015-05-28. Retrieved 2018-05-16.